Mawson Infrastructure
MIGI
Coinbase
COIN
Bit Digital
BTBT
Intchains Group
ICG
BTCS Inc
BTCS
US Stock MarketDetailed Quotes
ITCI Intra-Cellular Therapies
- 131.285
- +0.035+0.03%
Trading Mar 11 11:56 ET
13.96BMarket Cap-182.34P/E (TTM)
131.370High131.230Low980.62KVolume131.240Open131.250Pre Close128.73MTurnover0.94%Turnover RatioLossP/E (Static)106.33MShares131.37052wk High12.15P/B13.67BFloat Cap63.87052wk Low--Dividend TTM104.14MShs Float131.370Historical High--Div YieldTTM0.11%Amplitude6.750Historical Low131.271Avg Price1Lot Size
About Intra-Cellular Therapies Company
Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS. The firm’s lead product candidate, ITI-007, is in clinical development as a first-in-class treatment for schizophrenia. It also includes pre-clinical programs that are focused on advancing drug candidates for the treatment of cognitive dysfunction, in both schizophrenia and Alzheimer's disease and for disease modification and the treatment of neurodegenerative disorders, including Alzheimer's disease. The company was founded by Paul Greengard and Sharon Mates in 2002 and is headquartered in Bedminster, NJ.
Company Profile
SymbolITCI
Company NameIntra-Cellular Therapies
Listing DateJan 31, 2014
Founded2001
CEODr. Sharon Mates, PhD.
MarketNASDAQ
Employees860
Fiscal Year Ends12-31
Address135 Route 202/206,Suite 6
CityBedminster
ProvinceNew Jersey
CountryUnited States of America
Zip Code07921
Phone1-646-440-9333
Company Executives
- Name
- Position
- Salary
- Dr. Sharon Mates, PhD.
- Chairman of the Board and Chief Executive Officer
- 10.09M
- Sanjeev Narula
- Executive Vice President, Chief Financial Officer, Principal Accounting Officer and Treasurer
- --
- Mark Neumann
- Executive Vice President and Chief Commercial Officer
- 3.54M
- Dr. Suresh K. Durgam, M.D.
- Executive Vice President and Chief Medical Officer
- 3.51M
- Michael I. Halstead
- President
- 3.53M
- Rory B. Riggs
- Independent Director
- 470.51K
- Robert L. Van Nostrand
- Lead Independent Director
- 507.58K
- Eduardo Rene Salas
- Independent Director
- 461.30K
- Joel S. Marcus, J.D.
- Independent Director
- 473.34K
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.